Eclosion transforms the excellence of research into economic
value and employment, bringing solutions that allow the most promising project
to become a high performance company.
Moreover, Eclosion invests up to CHF 2 Mio private funds in the seeding
capital of new innovating companies with high potential in the life sciences
area. This sector covers particularly the pharma, biotech and medtech areas.
Investment criteria used by Eclosion are strictly based on the feasibility
and economic interest of the company, which can guarantee alone a long-term,
real employment, and value creation. |
|
French
version 
